Unsatisfactory Pap in a Postmenopausal Woman with Bleeding
A 63-year-old postmenopausal woman with a 3-month history of postcoital spotting has a Pap test reported as unsatisfactory for evaluation because of obscuring blood and inflammation; no endocervical or transformation-zone component is seen. She has no prior abnormal Pap and no history of HPV testing. The clinician calls the laboratory asking whether the unsatisfactory result can simply be repeated in 6 months and whether the bleeding can be attributed to atrophy. The laboratory's policy follows the Bethesda System for reporting and risk-based management.
1. How should the unsatisfactory result and the clinical presentation be interpreted together?
Read the worked answer
An unsatisfactory Pap due to obscuring blood and inflammation provides no evaluable information, so it cannot be used to exclude cervical or endometrial disease. In a 63-year-old postmenopausal woman with postcoital spotting, the differential includes atrophic vaginitis, cervical or endometrial atrophy, cervical dysplasia or cancer, endometrial hyperplasia or carcinoma, and other genital tract lesions. Postcoital bleeding in a postmenopausal woman is a red flag that warrants evaluation beyond a repeat Pap: it is not adequately explained by atrophy without excluding structural and neoplastic causes. The absence of a transformation-zone component further limits the sensitivity of the test.
2. What follow-up and workup are appropriate, and what should the laboratory recommend?
Read the worked answer
The unsatisfactory Pap should be repeated after treatment of inflammation or bleeding, but the postcoital bleeding requires concurrent clinical evaluation rather than a 6-month wait. Appropriate workup includes a pelvic examination, colposcopy with directed biopsy if a cervical lesion is seen, and endometrial sampling (office biopsy or dilation and curettage) to evaluate for endometrial pathology, especially given postmenopausal bleeding. HPV testing may be incorporated per local algorithms but does not replace tissue evaluation in this setting. The laboratory should communicate that the unsatisfactory result is non-diagnostic, that the clinical symptoms mandate prompt gynecologic evaluation, and that repeat cytology alone is insufficient. The report should state the reason for unsatisfactory status and recommend clinical correlation.